GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) » Definitions » Days Payable

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Days Payable : 111.48 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hubei Biocause Heilen Pharmaceutical Co Days Payable?

Hubei Biocause Heilen Pharmaceutical Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥104.7 Mil. Hubei Biocause Heilen Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥85.7 Mil. Hence, Hubei Biocause Heilen Pharmaceutical Co's Days Payable for the three months ended in Mar. 2024 was 111.48.

The historical rank and industry rank for Hubei Biocause Heilen Pharmaceutical Co's Days Payable or its related term are showing as below:

SZSE:301211' s Days Payable Range Over the Past 10 Years
Min: 37.31   Med: 50.56   Max: 94.05
Current: 94.05

During the past 7 years, Hubei Biocause Heilen Pharmaceutical Co's highest Days Payable was 94.05. The lowest was 37.31. And the median was 50.56.

SZSE:301211's Days Payable is ranked better than
53.99% of 978 companies
in the Drug Manufacturers industry
Industry Median: 86.975 vs SZSE:301211: 94.05

Hubei Biocause Heilen Pharmaceutical Co's Days Payable increased from Mar. 2023 (49.74) to Mar. 2024 (111.48). It may suggest that Hubei Biocause Heilen Pharmaceutical Co delayed paying its suppliers.


Hubei Biocause Heilen Pharmaceutical Co Days Payable Historical Data

The historical data trend for Hubei Biocause Heilen Pharmaceutical Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Heilen Pharmaceutical Co Days Payable Chart

Hubei Biocause Heilen Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial 44.73 47.20 37.31 59.18 92.16

Hubei Biocause Heilen Pharmaceutical Co Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.74 61.71 110.58 124.65 111.48

Competitive Comparison of Hubei Biocause Heilen Pharmaceutical Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Biocause Heilen Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Biocause Heilen Pharmaceutical Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Biocause Heilen Pharmaceutical Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Hubei Biocause Heilen Pharmaceutical Co's Days Payable falls into.



Hubei Biocause Heilen Pharmaceutical Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hubei Biocause Heilen Pharmaceutical Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (82.621 + 117.695) / 2 ) / 396.675*365
=100.158 / 396.675*365
=92.16

Hubei Biocause Heilen Pharmaceutical Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (117.695 + 91.732) / 2 ) / 85.712*365 / 4
=104.7135 / 85.712*365 / 4
=111.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hubei Biocause Heilen Pharmaceutical Co Days Payable Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Heilen Pharmaceutical Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Business Description

Traded in Other Exchanges
N/A
Address
No. 122, Yangwan Road, Dadao District, Jingmen High-tech Zone, Hubei Province, Jingmen, CHN, 448000
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.

Hubei Biocause Heilen Pharmaceutical Co (SZSE:301211) Headlines

No Headlines